SaigonBao.com

Archive -Daily News

CRISPR Therapy

CRISPR : 2025January06Monday

CRISPR Repairs Limb-Girdle Muscular Dystrophy 2B Mutation and Phenotypes in Patient-Derived Cells and Mouse Model - CRISPR Medicine News

Lightning Round: I want to own CRISPR, says Jim Cramer - MSN

The World’s First Crispr Drug Gets a Slow Start - WIRED

CRISPR-StAR enables high-resolution genetic screening in complex in vivo models - Nature.com

For kids with rare genetic disorders, customized CRISPR treatments offer hope - NPR

CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy - nejm.org

CRISPR builds a big tomato that’s actually sweet - Nature.com

Combining AI and Crispr Will Be Transformational - WIRED

CRISPR genome-editing grows up: advanced therapies head for the clinic - Nature.com

1 Big New Green Flag for CRISPR Therapeutics' Stock - The Motley Fool

Genetic Engineering: 2025January06Monday

Genetic engineering - DNA Modification, Cloning, Gene Splicing - Britannica

Genetic engineering and the eye - Nature.com

Undergraduates earn gold in genetic engineering contest - Stanford University News

Genetic Engineering Hides Donor Organs from Host Immune System - The Scientist

Clemson professor’s research focuses on identifying unintended effects of genetic engineering process in crops - Clemson News

These Plants Aren’t for Decoration—They’re for Science - Boston University

Engineering Cancer Cells to Short-Circuit Treatment Resistance - NCI Cancer Bulletin

Agricultural Biotechnology - FDA.gov

Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine - Frontiers

The great gene editing debate: can it be safe and ethical? - BBC.com

Gene Editing : 2025January06Monday

Gene editing | Definition, History, & CRISPR-Cas9 - Britannica

Gene-editing in patient and humanized-mice primary muscle stem cells rescues dysferlin expression in dysferlin-deficient muscular dystrophy - Nature.com

Guidance on Foods Derived from Plants Produced Using Genome Editing - FDA.gov

4 companies to watch in the accelerating gene editing race - PharmaVoice

What is CRISPR? A bioengineer explains - Stanford University News

CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy - nejm.org

Future-proofing Food and Agriculture: NC State’s Genome Editing Center - NC State CALS

$14M grant funds rare metabolic disease gene-editing research - Penn Medicine

Mitigating Risks from Gene Editing and Synthetic Biology: Global Governance Priorities - Carnegie Endowment for International Peace

JCR Pharmaceuticals and Modalis Therapeutics Announce Transition to the Next Phase of Joint Research Agreement for Development of Novel Gene Therapy - Business Wire

CRISPR Therapy : 2025January06Monday

CRISPR-Based Therapy for Hereditary Angioedema - nejm.org

Chemical engineering of CRISPR–Cas systems for therapeutic application - Nature.com

What is CRISPR? A bioengineer explains - Stanford University News

Letter: The risk-benefit balance of CRISPR-Cas screening systems in gene editing and targeted cancer therapy - Journal of Translational Medicine

Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy - Frontiers

CRISPR therapies can treat disease but cost millions. An equity-based approach could bring them to more people - Bulletin of the Atomic Scientists

CRISPR Therapeutics AG (CRSP): Is This Gene Therapy Stock a Good Buy Right Now? - Yahoo Finance

CRISPR Gene Therapy for Sickle Cell Disease - Mass General Brigham

Editas, changing course again, looks to partner lead CRISPR therapy - BioPharma Dive

UK's NHS to roll out Vertex/CRISPR gene therapy for rare blood disorder - Reuters